HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism

Jian Cui(Nanchang University)
Journal of Translational Medicine
February 15, 2023
Cited by 15


Related Papers